Following 111, Inc.'s strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone. On May 24, 111 and MSH, a world leader in the design and management of international healthcare solution, announced a strategic partnership aiming to combine resources to establish a comprehensive "diagnosis + medication + payment" Internet pharmaceutical and healthcare service closed-loop system by launching online diagnoses, prescription purchase and delivery, refills, health monitoring, patient management services, and enhance the pharmacy benefit management ("PBM") model.

Currently, the percentage of patients with chronic diseases in China continues to increase rapidly due to factors such as an intensive aging population and environmental pollution. Given the high number of chronically ill patients in China, the need for long term medications, high drug prices, and reliance on physician refills, the "Internet + insurance" model will aim to lessen the burden of chronically ill patients by providing them with a new solution to purchase and refill medications.

As a leader in China's Internet pharmaceutical and healthcare industry, 111 has built an integrated online and offline healthcare new retail platform which includes 111's B2C pharmaceutical platform "1 Drugstore", online medical services internet hospital "1 Clinic", and online wholesale pharmacy "1 Drug Mall". The fully integrated online to offline platform effectively combines patient medical services with drugs, B and C-side clients, and direct sales platform through our innovative T2B2C model. The company aims to build an integrated online and offline healthcare ecosystem to empower doctors, pharmacies, hospitals and clinics, pharmaceutical companies and insurance companies.

Register as Visitor to CPhI China 2019 NOW!

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com.